{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:48:27Z","timestamp":1789778907124,"version":"4.0.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T00:00:00Z","timestamp":1730764800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010133","name":"Aarne Koskelon Saatio","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010133","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005633","name":"Syd\u00e4ntutkimuss\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008376","name":"Helsinki and Uusimaa Healthcare District","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008376","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Clinical Electrophysiology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.jacep.2024.10.029","type":"journal-article","created":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T15:14:54Z","timestamp":1734534894000},"page":"583-592","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Temporal Trends of Ischemic Stroke Risk in Patients With Incident Atrial Fibrillation Before Anticoagulation"],"prefix":"10.1016","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4460-0994","authenticated-orcid":false,"given":"Konsta","family":"Teppo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.E. Juhani","family":"Airaksinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olli","family":"Halminen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jussi","family":"Jaakkola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jari","family":"Haukka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elis","family":"Kouki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Luojus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jukka","family":"Putaala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgitta","family":"Salmela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miika","family":"Linna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aapo L.","family":"Aro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pirjo","family":"Mustonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juha","family":"Hartikainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory Y.H.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mika","family":"Lehto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacep.2024.10.029_bib1","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2022-002140","article-title":"Comprehensive nationwide incidence and prevalence trends of atrial fibrillation in Finland","volume":"9","author":"Lehto","year":"2022","journal-title":"Open Heart"},{"issue":"2","key":"10.1016\/j.jacep.2024.10.029_bib2","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on atrial fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"issue":"11","key":"10.1016\/j.jacep.2024.10.029_bib3","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1161\/STROKEAHA.113.002329","article-title":"Atrial fibrillation, stroke risk, and warfarin therapy revisited: a population-based study","volume":"44","author":"Bj\u00f6rck","year":"2013","journal-title":"Stroke"},{"issue":"5","key":"10.1016\/j.jacep.2024.10.029_bib4","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.jacep.2024.10.029_bib5","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jacc.2023.08.017","article-title":"2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"83","author":"Joglar","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacep.2024.10.029_bib6","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1055\/s-0041-1739411","article-title":"2021 focused update consensus guidelines of the Asia Pacific Heart Rhythm Society on Stroke Prevention in Atrial Fibrillation: executive summary","volume":"122","author":"Chao","year":"2022","journal-title":"Thromb Haemost"},{"issue":"9","key":"10.1016\/j.jacep.2024.10.029_bib7","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1161\/STROKEAHA.118.021990","article-title":"Improved stroke prevention in atrial fibrillation after the introduction of non-Vitamin K antagonist oral anticoagulants: the Stockholm experience","volume":"49","author":"Forslund","year":"2018","journal-title":"Stroke"},{"key":"10.1016\/j.jacep.2024.10.029_bib8","doi-asserted-by":"crossref","first-page":"100596","DOI":"10.1016\/j.lanepe.2023.100596","article-title":"Time trends in atrial fibrillation-related stroke during 2001\u20132020 in Sweden: a nationwide, observational study","volume":"28","author":"Ding","year":"2023","journal-title":"Lancet Reg Health Eur"},{"issue":"7","key":"10.1016\/j.jacep.2024.10.029_bib9","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/ehjqcco\/qcac086","article-title":"Trends in treatment and outcomes of atrial fibrillation during 2007-17 in Finland","volume":"9","author":"Teppo","year":"2023","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"10.1016\/j.jacep.2024.10.029_bib10","doi-asserted-by":"crossref","first-page":"27410","DOI":"10.1038\/srep27410","article-title":"Stroke and thromboembolic event rates in atrial fibrillation according to different guideline treatment thresholds: a nationwide cohort study","volume":"6","author":"Nielsen","year":"2016","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.jacep.2024.10.029_bib11","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s10654-021-00812-x","article-title":"The nationwide Finnish anticoagulation in atrial fibrillation (FinACAF): study rationale, design, and patient characteristics","volume":"37","author":"Lehto","year":"2022","journal-title":"Eur J Epidemiol"},{"issue":"10","key":"10.1016\/j.jacep.2024.10.029_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0276612","article-title":"Rural-urban differences in the initiation of oral anticoagulant therapy in patients with incident atrial fibrillation: a Finnish nationwide cohort study","volume":"17","author":"Teppo","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.jacep.2024.10.029_bib13","article-title":"Socioeconomic disparities in use of rhythm control therapies in patients with incident atrial fibrillation: a Finnish nationwide cohort study","volume":"41","author":"Teppo","year":"2022","journal-title":"Int J Cardiol Heart Vasc"},{"issue":"5","key":"10.1016\/j.jacep.2024.10.029_bib14","doi-asserted-by":"crossref","first-page":"e0176846","DOI":"10.1371\/journal.pone.0176846","article-title":"Patients with atrial fibrillation and outcomes of cerebral infarction in those with treatment of warfarin versus no warfarin with references to CHA2DS2-VASc score, age and sex\u2014a Swedish nationwide observational study with 48 433 patients","volume":"12","author":"Andersson","year":"2017","journal-title":"PLoS One"},{"issue":"7792","key":"10.1016\/j.jacep.2024.10.029_bib15","doi-asserted-by":"crossref","first-page":"d124","DOI":"10.1136\/bmj.d124","article-title":"Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study","volume":"342","author":"Olesen","year":"2011","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.jacep.2024.10.029_bib16","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/ehjcvp\/pvw022","article-title":"Treatment thresholds for stroke prevention in atrial fibrillation: observations on the CHA2DS2-VASc score","volume":"3","author":"Overvad","year":"2017","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"issue":"8","key":"10.1016\/j.jacep.2024.10.029_bib17","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1136\/jech-2022-219190","article-title":"Income and outcomes of patients with incident atrial fibrillation","volume":"76","author":"Biancari","year":"2022","journal-title":"J\u00a0Epidemiol Community Health"},{"issue":"1","key":"10.1016\/j.jacep.2024.10.029_bib18","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1161\/STROKEAHA.123.044448","article-title":"Ischemic stroke temporally associated with new-onset atrial fibrillation: a population-based registry-linkage study","volume":"55","author":"Putaala","year":"2024","journal-title":"Stroke"},{"issue":"5","key":"10.1016\/j.jacep.2024.10.029_bib19","first-page":"611","article-title":"Importance of risk reassessment in patients with atrial fibrillation in guidelines: assessing risk as a dynamic process","volume":"35","author":"Chang","year":"2019","journal-title":"Can J Cardiol"},{"issue":"12","key":"10.1016\/j.jacep.2024.10.029_bib20","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1161\/CIR.0000000000000558","article-title":"Heart disease and stroke statistics\u20142018 update: a report from the American Heart Association","volume":"137","author":"Benjamin","year":"2018","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.jacep.2024.10.029_bib21","first-page":"1","article-title":"Lexis: an R class for epidemiological studies with long-term follow-up","volume":"38","author":"Plummer","year":"2011","journal-title":"J\u00a0Stat Softw"},{"issue":"1","key":"10.1016\/j.jacep.2024.10.029_bib22","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1161\/CIRCOUTCOMES.110.958108","article-title":"Moving the tipping point the decision to anticoagulate patients with atrial fibrillation","volume":"4","author":"Eckman","year":"2011","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"8","key":"10.1016\/j.jacep.2024.10.029_bib23","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1161\/CIRCULATIONAHA.117.029081","article-title":"Female sex is a risk modifier rather than a risk factor for stroke in atrial fibrillation should we use a CHA2DS2-VA score rather than CHA2DS2-VASc?","volume":"137","author":"Nielsen","year":"2018","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.jacep.2024.10.029_bib24","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1161\/CIRCULATIONAHA.116.024057","article-title":"Wide variation in reported rates of stroke across cohorts of patients with atrial fibrillation","volume":"135","author":"Quinn","year":"2017","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.jacep.2024.10.029_bib25","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.ijcard.2012.10.052","article-title":"Validation of contemporary stroke and bleeding risk stratification scores in non-anticoagulated Chinese patients with atrial fibrillation","volume":"168","author":"Guo","year":"2013","journal-title":"Int J Cardiol"},{"issue":"1","key":"10.1016\/j.jacep.2024.10.029_bib26","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1093\/eurheartj\/ehae198","article-title":"Ischaemic stroke in women with atrial fibrillation: temporal trends and clinical implications","volume":"45","author":"Teppo","year":"2024","journal-title":"Eur Heart J"},{"issue":"10","key":"10.1016\/j.jacep.2024.10.029_bib27","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S1474-4422(21)00252-0","article-title":"Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"20","author":"Feigin","year":"2021","journal-title":"Lancet Neurol"},{"issue":"2","key":"10.1016\/j.jacep.2024.10.029_bib28","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1177\/1747493019897870","article-title":"Global epidemiology of atrial fibrillation: an increasing epidemic and public health challenge","volume":"16","author":"Lippi","year":"2021","journal-title":"Int J Stroke"},{"issue":"34","key":"10.1016\/j.jacep.2024.10.029_bib29","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1093\/eurheartj\/eht280","article-title":"Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060","volume":"35","author":"Krijthe","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacep.2024.10.029_bib30","article-title":"Atrial fibrillation: stroke prevention","volume":"37","author":"Chao","year":"2024","journal-title":"Lancet Reg Health Eur"},{"issue":"1","key":"10.1016\/j.jacep.2024.10.029_bib31","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000519465","article-title":"Current recommendations on atrial fibrillation: a comparison of the recent European and Canadian guidelines","volume":"147","author":"Okutucu","year":"2022","journal-title":"Cardiology"},{"issue":"6","key":"10.1016\/j.jacep.2024.10.029_bib32","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1160\/TH12-03-0175","article-title":"The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0-1: a nationwide cohort study","volume":"107","author":"Olesen","year":"2012","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jacep.2024.10.029_bib33","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1056\/NEJMoa2303062","article-title":"Anticoagulation with edoxaban in patients with atrial high-rate episodes","volume":"389","author":"Kirchhof","year":"2023","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.jacep.2024.10.029_bib34","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa2310234","article-title":"Apixaban for stroke prevention in subclinical atrial fibrillation","volume":"390","author":"Healey","year":"2023","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.jacep.2024.10.029_bib35","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1055\/a-1515-9630","article-title":"Adherence to the \u201cAtrial Fibrillation Better Care\u201d pathway in patients with atrial fibrillation: impact on clinical outcomes\u2014a systematic review and meta-analysis of 285,000 patients","volume":"122","author":"Romiti","year":"2022","journal-title":"Thromb Haemost"},{"issue":"5","key":"10.1016\/j.jacep.2024.10.029_bib36","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1177\/1559827620910981","article-title":"The North Karelia project: prevention of cardiovascular disease in Finland through population-based lifestyle interventions","volume":"14","author":"Puska","year":"2020","journal-title":"Am J Lifestyle Med"},{"issue":"8","key":"10.1016\/j.jacep.2024.10.029_bib37","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1177\/14034948221104351","article-title":"Contribution of smoking change to 45-year trend in prevalence of chronic bronchitis in Finland","volume":"51","author":"Vartiainen","year":"2023","journal-title":"Scand J Public Health"},{"issue":"1","key":"10.1016\/j.jacep.2024.10.029_bib38","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1540-8167.2010.01858.x","article-title":"Stroke risk stratification in a \u201creal-world\u201d elderly anticoagulated atrial fibrillation population","volume":"22","author":"Poli","year":"2011","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"issue":"6","key":"10.1016\/j.jacep.2024.10.029_bib39","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1177\/1403494812456637","article-title":"Quality of the Finnish Hospital Discharge Register: a systematic review","volume":"40","author":"Sund","year":"2012","journal-title":"Scand J Public Health"},{"issue":"47","key":"10.1016\/j.jacep.2024.10.029_bib40","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.1093\/eurheartj\/ehac111","article-title":"Oral anticoagulants in patients with atrial fibrillation at low stroke risk: a multicentre observational study","volume":"43","author":"Komen","year":"2022","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.jacep.2024.10.029_bib41","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/eurheartj\/ehad659","article-title":"Stroke and bleeding risk in atrial fibrillation with CHA2DS2-VASC risk score of one: the Norwegian AFNOR study","volume":"45","author":"Anjum","year":"2024","journal-title":"Eur Heart J"}],"container-title":["JACC: Clinical Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405500X24009393?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405500X24009393?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T17:30:29Z","timestamp":1762623029000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405500X24009393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S2405500X24009393"],"URL":"https:\/\/doi.org\/10.1016\/j.jacep.2024.10.029","relation":{},"ISSN":["2405-500X"],"issn-type":[{"value":"2405-500X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Temporal Trends of Ischemic Stroke Risk in Patients With Incident Atrial Fibrillation Before Anticoagulation","name":"articletitle","label":"Article Title"},{"value":"JACC: Clinical Electrophysiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacep.2024.10.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}]}}